Sox9 knockout mice have improved recovery following stroke

Area of Science:

• Neuroscience
• Regenerative Medicine
• Molecular Biology

Background:

• Stroke-induced recovery relies on neural plasticity, but is hindered by central nervous system growth inhibitors.
• Chondroitin sulfate proteoglycans (CSPGs) are key inhibitors of axonal sprouting, limiting functional recovery post-stroke.
• SOX9 is a transcription factor that up-regulates CSPG production, negatively impacting neural repair.

Purpose of the Study:

• To investigate the therapeutic potential of SOX9 inhibition in a stroke model.
• To evaluate the effects of conditional Sox9 ablation on CSPG levels, tissue sparing, and neurological recovery after stroke.

Main Methods:

• Utilized a transient middle cerebral artery occlusion (MCAO) model in mice.
• Generated conditional Sox9 knockout mice to study the effects of SOX9 ablation.
• Assessed CSPG levels, tissue sparing, and neurological deficits.
• Performed anterograde tract tracing to analyze axonal sprouting and projection patterns.

Main Results:

• Conditional Sox9 ablation significantly reduced CSPG levels in the stroke model.
• Sox9 knockout mice exhibited increased tissue sparing and improved neurological recovery.
• Enhanced sprouting of corticorubral and corticospinal projections from the uninjured cortex was observed.

Conclusions:

• Targeting SOX9 is a viable strategy to reduce CSPG-mediated inhibition of axonal growth.
• SOX9 ablation promotes neuroprotection and enhances functional recovery after stroke.
• This research opens new avenues for stroke treatment by modulating neural repair mechanisms.